InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（9 笔）
内部人交易记录
首席财务官已披露买入
1
已披露卖出
9
T+90 胜率
0%
T+90 平均收益
-13.4%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the complete record of transactions filed by Levy Adam Scott, 首席财务官. Officer active across 1 company, notably Mineralys Therapeutics, Inc.. In total, 12 disclosures have been published. Split: 1 buy · 9 sells. Total volume traded: €2.6m. Activity tracked since 14 February 2023. The latest transaction was filed on 19 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Levy Adam Scott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
39,900 股0Common StockSEC:0001933414-26-000037:0
10,758 股@ US$32.13640.013% mcap20.6% 占其流量Common StockSEC:0001693134-26-000002:0
20,547 股@ US$10.206.6% 占其流量Common StockSEC:0001933414-25-000152:0
7,366 股@ US$41.90210.012% mcap18.5% 占其流量Common StockSEC:0001933414-25-000130:0
12,946 股@ US$14.04320.0069% mcap10.9% 占其流量Common StockSEC:0001933414-25-000081:0
10,758 股@ US$14.45015.1% 占其流量Common StockSEC:0001933414-25-000077:0
10,757 股@ US$12.05583.6% 占其流量Common StockSEC:0001933414-25-000046:0
10,657 股@ US$9.09273.0% 占其流量Common StockSEC:0001933414-25-000005:0
10,757 股@ US$13.57294.2% 占其流量Common StockSEC:0001933414-24-000047:0
10,757 股@ US$13.14444.1% 占其流量Common StockSEC:0001933414-24-000034:0
96,815 股@ US$12.939336.7% 占其流量Common StockSEC:0001933414-24-000027:0
6,250 股@ US$16.002.9% 占其流量Common StockSEC:0001628280-23-003924:0
标准退出：2023年5月15日 (T+90)
12 条申报中的 12 条
About Levy Adam Scott
Adam Scott Levy is the Chief Financial Officer and Secretary of Mineralys Therapeutics, Inc. He is responsible for the company's financial management, including budgeting and financial reporting. His role is crucial in ensuring financial transparency and supporting Mineralys's growth strategy.
